But for older patients who require antipsychotic treatment, quetiapine and clozapine are considered "less risky for causing ...

The KINECT-PRO™ analysis is the first and only of its kind to report both remission of tardive dyskinesia symptoms and associated improvements in patient-reported outcomes. Post-hoc analysis from ...

A new report seems to have undone years-old internal Johnson & Johnson discussions about the potential adverse link between ...

Dopamine, a key neurotransmitter in the brain, plays a vital role in regulating movement, emotion, and cognition. It is central to the pathology of several major neurological and psychiatric ...

After years of heartbreak, researchers have found an experimental treatment that can slow the progression of Huntington’s ...

Neurocrine (NBIX) announced new data from a post-hoc analysis of the Phase 4 KINECT-PRO open-label study confirming that robust rates of ...

Sen. Todd Young, R-Indiana, and Sen. Ruben Gallego, D-Arizona, introduced the Uplifting First-Time Homebuyers Act, ...

Huntington's disease findings were announced last month in a news release from uniQure, the company that sponsored the research.

I cried with every single patient,” Sung says. “It just was this crazy feeling that, for the patients and families, almost can’t feel real.” The treatment, known as AMT-130, is delivered deep into the ...

Trump Administration introduced what it says is an “exciting treatment” for autism: leucovorin, a decades-old medicine that treats toxic effects of chemotherapy. Early research suggests it can be ...

When most individuals are exposed to the term Alzheimer's disease, they immediately associate it with declining memory and ...

A first-of-its-kind gene therapy has shown encouraging results in slowing the progression of Huntington’s disease, a rare and ...